Ismael Zamora - Concepedia

Author

Ismael Zamora

AstraZeneca (Sweden)ORCID

Also Known As

Gerhard Wolber, I. ZAMORA, I. Zamora, Ingrid Daniela Santos Zamora, Ismael Zamora, Ismael Zamora Rico

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (Sweden)Universitat Pompeu Fabra Uppsala University Molecular Discovery (United Kingdom)Median SCP (Spain)

About

Ismael Zamora is an author at AstraZeneca (Sweden) specializing in medicine, biochemistry, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	19	1.2K
2	Biochemistry	17	19	1.2K
3	Natural Sciences	14	16	970
4	Engineering	7	7	484
5	Biology	1	1	76

Ismael Zamora

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
pH-Dependent Bidirectional Transport of Weakly Basic Drugs Across Caco-2 Monolayers: Implications for Drug–Drug Interactions Sibylle Neuhoff, Anna‐Lena Ungell, Ismael Zamora, Pharmaceutical Research	2003	207
pH-Dependent passive and active transport of acidic drugs across Caco-2 cell monolayers Sibylle Neuhoff, Anna‐Lena Ungell, Ismael Zamora, European Journal of Pharmaceutical Sciences Molecular PharmacologyAcidic DrugsProteinlipid InteractionBiochemistryCaco-2 Cell Monolayers	2005	147
Contribution of solid-state properties to the aqueous solubility of drugs Carola M. Wassvik, Anders Holmén, Christel A. S. Bergström, European Journal of Pharmaceutical Sciences Materials ScienceEngineeringAqueous SolubilityPhysicochemical AnalysisPhase Equilibrium	2006	139
Predicting Drug Metabolism: A Site of Metabolism Prediction Tool Applied to the Cytochrome P450 2C9 Ismael Zamora, Lovisa Afzelius, Gabriele Cruciani Journal of Medicinal Chemistry Bioorganic ChemistryMetabolomic ProfilingMetabolic ModelRedox BiologyCytochrome P450 2C9	2003	137
CYP2C9 Structure−Metabolism Relationships: Optimizing the Metabolic Stability of COX-2 Inhibitors Marie M. Ahlström, Marianne Ridderström, Ismael Zamora, Journal of Medicinal Chemistry Bioorganic ChemistryCox-2 Selective InhibitorMetabolic RemodelingCyp FamilyPharmaceutical Chemistry	2007	102
Competitive CYP2C9 Inhibitors: Enzyme Inhibition Studies, Protein Homology Modeling, and Three-Dimensional Quantitative Structure-Activity Relationship Analysis Lovisa Afzelius, Ismael Zamora, Marianne Ridderström, Molecular Pharmacology	2001	95
Enhanced metabolite identification with MS <sup>E</sup> and a semi‐automated software for structural elucidation Britta Bonn, Carina Leandersson, Fabien Fontaine, Rapid Communications in Mass Spectrometry	2010	91
Anchor−GRIND: Filling the Gap between Standard 3D QSAR and the GRid-INdependent Descriptors Fabien Fontaine, Manuel Pastor, Ismael Zamora, Journal of Medicinal Chemistry Drug TargetEngineeringAnchor PointMolecular BiologyStandard 3D	2005	89
SHOP: Scaffold HOPping by GRID-Based Similarity Searches Rikke Bergmann, Anna Linusson, Ismael Zamora Journal of Medicinal Chemistry Drug TargetMolecular BiologyRange SearchingComputer-aided DesignHiv Protease Scaffolds	2007	79
Pharmacokinetically Based Mapping Device for Chemical Space Navigation Tudor I. Oprea, Ismael Zamora, Anna‐Lena Ungell Journal of Combinatorial Chemistry EngineeringChemical AnalysisLocal PharmacologyQuantitative PharmacologyMapping Device	2002	77

Page 1